Acceptance and Commitment Therapy to improve Neuro-Oncology Wellbeing (ACT NOW)
- Conditions
- Psychosocial oncology and survivorship, mental health, psychological wellbeing, young brain tumour survivors, malignant neoplasms of eye, brain and other parts of central nervous systemCancerMalignant neoplasms of eye, brain and other parts of central nervous system
- Registration Number
- ISRCTN10903290
- Lead Sponsor
- ottingham University Hospitals NHS Trust
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34078638/ (added 13/08/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 72
1. Aged 11 to 24 years
2. Have had a historical primary diagnosis of brain tumour
3. Have stable disease and either off treatment or on low-intensity treatment
4. Sufficient understanding of English to engage with the intervention (spoken and written), as judged by the assessing clinician
5. Sufficient cognitive, sensory, and speech capabilities to take part in the intervention
6. Oral and written informed consent to participate in the study given by participants (or their parents if under 16)
7. Participants give written assent if under 16 years old
8. Access to the internet and appropriate devices to receive treatment over video-conferencing (the default modality for delivery). However, face-to-face treatment will be offered if internet access or appropriate device use is not possible for participants who are otherwise eligible.
1. Previous structured behavioural intervention within the last 6 months
2. Previous or current alcohol/substance dependence, psychosis, suicidality, or anorexia nervosa
3. Moderate/severe intellectual disability
4. Immediate risk to self or others
5. Parent or child not able to speak or read/write English
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method